170 related articles for article (PubMed ID: 17069901)
1. Nuclear Ca2+/calmodulin-dependent protein kinase II in the murine heart.
Li B; Dedman JR; Kaetzel MA
Biochim Biophys Acta; 2006 Nov; 1763(11):1275-81. PubMed ID: 17069901
[TBL] [Abstract][Full Text] [Related]
2. CaMKII inhibition targeted to the sarcoplasmic reticulum inhibits frequency-dependent acceleration of relaxation and Ca2+ current facilitation.
Picht E; DeSantiago J; Huke S; Kaetzel MA; Dedman JR; Bers DM
J Mol Cell Cardiol; 2007 Jan; 42(1):196-205. PubMed ID: 17052727
[TBL] [Abstract][Full Text] [Related]
3. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure.
Zhang T; Maier LS; Dalton ND; Miyamoto S; Ross J; Bers DM; Brown JH
Circ Res; 2003 May; 92(8):912-9. PubMed ID: 12676814
[TBL] [Abstract][Full Text] [Related]
4. The cardiac-specific nuclear delta(B) isoform of Ca2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity.
Zhang T; Johnson EN; Gu Y; Morissette MR; Sah VP; Gigena MS; Belke DD; Dillmann WH; Rogers TB; Schulman H; Ross J; Brown JH
J Biol Chem; 2002 Jan; 277(2):1261-7. PubMed ID: 11694533
[TBL] [Abstract][Full Text] [Related]
5. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy.
Khoo MS; Li J; Singh MV; Yang Y; Kannankeril P; Wu Y; Grueter CE; Guan X; Oddis CV; Zhang R; Mendes L; Ni G; Madu EC; Yang J; Bass M; Gomez RJ; Wadzinski BE; Olson EN; Colbran RJ; Anderson ME
Circulation; 2006 Sep; 114(13):1352-9. PubMed ID: 16982937
[TBL] [Abstract][Full Text] [Related]
6. Ca
Baier MJ; Klatt S; Hammer KP; Maier LS; Rokita AG
J Mol Cell Cardiol; 2020 Jan; 138():212-221. PubMed ID: 31836540
[TBL] [Abstract][Full Text] [Related]
7. Ca2+/calmodulin-dependent protein kinase IIdelta orchestrates G-protein-coupled receptor and electric field stimulation-induced cardiomyocyte hypertrophy.
Zhang W; Qi F; Chen DQ; Xiao WY; Wang J; Zhu WZ
Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):795-802. PubMed ID: 20374261
[TBL] [Abstract][Full Text] [Related]
8. Cardiomyocyte calcium and calcium/calmodulin-dependent protein kinase II: friends or foes?
Zhang T; Miyamoto S; Brown JH
Recent Prog Horm Res; 2004; 59():141-68. PubMed ID: 14749501
[TBL] [Abstract][Full Text] [Related]
9. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
10. Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure.
Zhang T; Brown JH
Cardiovasc Res; 2004 Aug; 63(3):476-86. PubMed ID: 15276473
[TBL] [Abstract][Full Text] [Related]
11. Chronic elevation of calmodulin in the ventricles of transgenic mice increases the autonomous activity of calmodulin-dependent protein kinase II, which regulates atrial natriuretic factor gene expression.
Colomer JM; Means AR
Mol Endocrinol; 2000 Aug; 14(8):1125-36. PubMed ID: 10935538
[TBL] [Abstract][Full Text] [Related]
12. CaMKII-mediated increased lusitropic responses to beta-adrenoreceptor stimulation in ANP-receptor deficient mice.
Yurukova S; Kilić A; Völker K; Leineweber K; Dybkova N; Maier LS; Brodde OE; Kuhn M
Cardiovasc Res; 2007 Mar; 73(4):678-88. PubMed ID: 17107670
[TBL] [Abstract][Full Text] [Related]
13. Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling.
Wu X; Zhang T; Bossuyt J; Li X; McKinsey TA; Dedman JR; Olson EN; Chen J; Brown JH; Bers DM
J Clin Invest; 2006 Mar; 116(3):675-82. PubMed ID: 16511602
[TBL] [Abstract][Full Text] [Related]
14. Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias.
Gonano LA; Sepúlveda M; Rico Y; Kaetzel M; Valverde CA; Dedman J; Mattiazzi A; Vila Petroff M
Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):947-57. PubMed ID: 22009705
[TBL] [Abstract][Full Text] [Related]
15. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury.
Vila-Petroff M; Salas MA; Said M; Valverde CA; Sapia L; Portiansky E; Hajjar RJ; Kranias EG; Mundiña-Weilenmann C; Mattiazzi A
Cardiovasc Res; 2007 Mar; 73(4):689-98. PubMed ID: 17217936
[TBL] [Abstract][Full Text] [Related]
16. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
[TBL] [Abstract][Full Text] [Related]
17. Calmodulin kinase II inhibition shortens action potential duration by upregulation of K+ currents.
Li J; Marionneau C; Zhang R; Shah V; Hell JW; Nerbonne JM; Anderson ME
Circ Res; 2006 Nov; 99(10):1092-9. PubMed ID: 17038644
[TBL] [Abstract][Full Text] [Related]
18. Calcium/calmodulin-dependent protein kinase IIdelta associates with the ryanodine receptor complex and regulates channel function in rabbit heart.
Currie S; Loughrey CM; Craig MA; Smith GL
Biochem J; 2004 Jan; 377(Pt 2):357-66. PubMed ID: 14556649
[TBL] [Abstract][Full Text] [Related]
19. The CaMKII phosphorylation site Thr1604 in the Ca
Li J; Wang S; Zhang J; Liu Y; Zheng X; Ding F; Sun X; Zhao M; Hao L
Channels (Austin); 2020 Dec; 14(1):151-162. PubMed ID: 32290730
[TBL] [Abstract][Full Text] [Related]
20. Calmodulin kinase II inhibition protects against structural heart disease.
Zhang R; Khoo MS; Wu Y; Yang Y; Grueter CE; Ni G; Price EE; Thiel W; Guatimosim S; Song LS; Madu EC; Shah AN; Vishnivetskaya TA; Atkinson JB; Gurevich VV; Salama G; Lederer WJ; Colbran RJ; Anderson ME
Nat Med; 2005 Apr; 11(4):409-17. PubMed ID: 15793582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
